Abstract
A 62-year-old female who is status post total hysterectomy and bilateral salphyngoopherectomy had the diagnosis of malignant mixed Müllerian tumor and is now being evaluated for restaging with 18F-FDG PET/CT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Avril N, Sassen S, Schmalfeldt B, Naehrig J, Rutke S, Weber WA, et al. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol. 2005;23:7445–53.
Bhoil A, Kashyap R, Bhattacharya A, Mittal BR. F-18 fluorodeoxyglucose positron emission tomography/computed tomography in a rare case of recurrent malignant mixed mullerian tumor. World J Nucl Med. 2014;13:64–6. doi:10.4103/1450-1147.138578.
Brennan MJ. Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment. J Pain Symptom Manage. 1992;7:110–6.
Chou HH, Chang TC, Yen TC, Ng KK, Hsueh S, Ma SY, et al. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol. 2006;24:123–8.
Funicelli L, Travaini LL, Landoni F, Trifirò G, Bonello L, Bellomi M. Peritoneal arcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT. Abdom Imaging. 2010;35:701–7. doi:10.1007/s00261-009-9578-8.
Herrera FG, Prior JO. The role of PET/CT in cervical cancer. Front Oncol. 2013;3:34. doi:10.3389/fonc.2013.00034.
Kanthan R, Senger JL. Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int. 2011;2011:470795 doi:10.1155/2011/470795
Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positronemission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28:2108–13.
Kim HW, Won KS, Zeon SK, Ahn BC, Gayed IW. Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT. Clin Nucl Med. 2013;38:93–7. doi:10.1097/RLU.0b013e31826390ec.
Mortimer PS. The pathophysiology of lymphedema. Cancer. 1998;83:2798–802.
Nishiyama Y, Yamamoto Y, Kanenishi K, Ohno M, Hata T, Kushida Y, et al. Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET. Eur J Nucl Med Mol Imaging. 2008;35:287–95.
Ozulker T, Ozulker F, Ozpacaci T. 99mTc-MDP and 18F-FDG uptake in calcified metastatic lesions from ovarian papillary serous adenocarcinoma. Hell J Nucl Med. 2009;12:287–8.
Park JY, Kim EN, Kim DY, Suh DS, Kim JH, Kim YM, et al. Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma. Gynecol Oncol. 2008;109:255–62.
Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, Ihling C, Högerle S, Mix M, et al. Metastatic lymph nodes in patients with cervical cancer:detection with MR imaging and FDG PET. Radiology. 2001;218:776–82.
Roh JW, Seo SS, Lee S, Kang KW, Kim SK, Sim JS, et al. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. Eur J Cancer. 2005;41:2086–92.
Rong-Hsin Yang, Yum-Kung Chu. 18F-FDG PET/CT findings of omental cake: a case report. Ann Nucl Med Sci. 2010;23:93–7.
Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol. 1999;17:41–5.
Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med. 2003;44:347–52.
Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. J Nucl Med. 2009;50 Suppl 1:64–73. doi:10.2967/jnumed.108.057257.
Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology. 2006;238:272–9.
Tada H, Teramukai S, Fukushima M, Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:47. doi:10.1186/1471-2407-9-47.
Wright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS, et al. Preoperative lymph node staging of early stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer. 2005;104:2484–91.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Özülker, T., Özülker, F. (2015). Gynecologic Tumors. In: Atlas of PET-CT Imaging in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18994-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-18994-9_14
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18993-2
Online ISBN: 978-3-319-18994-9
eBook Packages: MedicineMedicine (R0)